Human monoclonal antibodies against CD25

Details for Australian Patent Application No. 2003295471 (hide)

Owner Genmab A/S

Inventors Havenith, Catharina Emanuele Gerarda; Baadsgaard, Ole D. M. Sc.; Van De Winkel, Jan G. J.; Petersen, Jorgen; Williams, Denise Leah; Schuurman, Janine; Parren, Paul

Agent Watermark

Pub. Number AU-B-2003295471

PCT Number PCT/US2003/0361

PCT Pub. Number WO2004/045512

Priority 60/426,690 15.11.02 US

Filing date 14 November 2003

Wipo publication date 15 June 2004

Acceptance publication date 25 August 2011

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

G01N 33/68 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

Event Publications

22 April 2004 Complete Application Filed

  Priority application(s): 60/426,690 15.11.02 US

15 July 2004 Application Open to Public Inspection

  Published as AU-B-2003295471

25 August 2011 Application Accepted

  Published as AU-B-2003295471

22 December 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003295472-A PANCREATIC ISLET TRANSCRIPTION FACTOR AND USES THEREOF

2003295470-METHODS AND COMPOSITIONS FOR INDUCING IMMUNE RESPONSES AND PROTECTIVE IMMUNITY BY PRIMING WITH ALPHAVIRUS REPLICON VACCINES